Ville Haaslahti

Ville Haaslahti serves as CEO at Hidex Oy. Hidex Oy operates in the medical devices sector with approximately 32.0 employees. The company is headquartered in Turku.

Industry & Role Insights

• • MessageCEO tracks 1,888 executives in the medical devices sector.
• • Our database includes 201,468 c suite-level executives.

Sendgrid Outlook Google Analytics Nginx Google Tag Manager Shutterstock Linkedin Marketing Solutions Amadesa DoubleClick Conversion Mobile Friendly Google Font API WordPress.org Google Dynamic Remarketing Bing Ads DoubleClick Visual Website Optimizer reCAPTCHA AI

radiation detection radiation measurement liquid scintillation counting nuclear medicine life science research analytical equipment high technology laboratory equipment microplate reader gamma counter gamma counting alpha beta gamma counting medical equipment manufacturing liquid scintillation counters sample preparation gamma counters microplate readers pet radiochemistry reagents consumables scintillation cocktails radiopharmaceuticals biocarbon analysis environmental radioactivity agrochemical industry life sciences radiation protection biocarbon method biofuel method iq/oq validation support services installation services service contracts high performance analysis alpha beta gamma detection automated systems ultra low level lsc hidex 600 ox oxidizer hidex q-are gamma counting standards multimode readers radiometric detection triathler scientific research nuclear industry advanced technology sensitivity optimization sample capacity portable liquid scintillation counter hidex sense beta plus hidex 300 sl luminometry qc standards extraction chromatography reliable instruments clinical applications research tools automated radiochemical separation sustainable energy analysis medical devices hospital & health care

YM

Yahia Megahed CEO at 360Imaging

HA

Hugo Azevedo Chief Technology Officer at 3B Scientific

MP

Marie-Laure Pochon CEO & President at 3DISC

KD

Khanh Duy Co-CEO at 3D-Side

K

Khanh Co-CEO at 3D-Side

Outreach Guidance — medical devices Sector

Executives like Ville Haaslahti in the medical devices sector receive targeted outreach from sales teams, recruiters, and investors. To stand out, personalize your message with industry-specific context and a clear, specific value proposition relevant to their role at Hidex Oy.

Ville Haaslahti's Position in the MessageCEO Database

• •Ville Haaslahti is 1 of 1 verified executive contact we track at Hidex Oy.
• •1,787 verified executive contacts in medical devices are in the MessageCEO database.
• •25 verified contacts work at medical devices companies in the 32.0 employee range (same size as Hidex Oy).

Executive contact data compiled from public business filings, LinkedIn public profiles, company press materials, and verified outbound email testing. We do not publish personal addresses or sensitive identifiers. Methodology & sources · Removal requests handled at /remove-info · Updated July 2026.

How do I reach Ville Haaslahti directly?

Ville Haaslahti's verified email address is available to MessageCEO Pro subscribers. They currently serve as CEO at Hidex Oy. Access direct contact info to skip gatekeepers and reach the decision maker.

What company does Ville Haaslahti work for?

Ville Haaslahti is CEO at Hidex Oy, a company in the medical devices sector with 32.0 employees. The company is based in Turku.

Can I pitch or sell to Ville Haaslahti?

As CEO at Hidex Oy, Ville Haaslahti is a key decision-maker in the medical devices sector. MessageCEO Pro gives you verified email to reach Ville Haaslahti directly — ideal for B2B sales, partnerships, and executive recruiting.

What industry is Ville Haaslahti in?

Ville Haaslahti works in the medical devices industry as CEO at Hidex Oy. MessageCEO provides verified contact information for executives across all major industries.

Is Ville Haaslahti's contact information verified?

Yes. MessageCEO verifies executive contact information through multiple data sources and regular validation checks. Ville Haaslahti's profile is kept up-to-date with the latest available information.

Last updated: July 25, 2026